![]() |
Volumn 84, Issue 12 S SUPPL., 2007, Pages
|
Double-filtration plasmapheresis
|
Author keywords
ABO incompatible; Double filtration plasmapheresis; Kidney; Transplantation
|
Indexed keywords
BASILIXIMAB;
BLOOD GROUP A ANTIBODY;
BLOOD GROUP B ANTIBODY;
IMMUNOGLOBULIN;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
RITUXIMAB;
TACROLIMUS;
ADULT;
ANTIBODY TITER;
BLOOD GROUP ABO INCOMPATIBILITY;
CENTRIFUGATION;
CLINICAL ARTICLE;
CLINICAL PROTOCOL;
CONFERENCE PAPER;
CONTROLLED STUDY;
DILUTION;
DOUBLE FILTRATION PLASMAPHERESIS;
DRUG DOSE REDUCTION;
FEMALE;
HUMAN;
HYPERACUTE GRAFT REJECTION;
IMMUNOADSORPTION;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY TRANSPLANTATION;
LIVING DONOR;
MALE;
PLASMAPHERESIS;
PRIORITY JOURNAL;
RECIPIENT;
SPLENECTOMY;
ABO BLOOD-GROUP SYSTEM;
ALBUMINS;
BLOOD GROUP INCOMPATIBILITY;
EQUIPMENT DESIGN;
FLOW CYTOMETRY;
GRAFT REJECTION;
HUMANS;
IMMUNOGLOBULIN G;
IMMUNOGLOBULIN M;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
PLASMAPHERESIS;
REPRODUCIBILITY OF RESULTS;
TIME FACTORS;
|
EID: 37549049397
PISSN: 00411337
EISSN: None
Source Type: Journal
DOI: 10.1097/01.tp.0000296103.34735.b8 Document Type: Conference Paper |
Times cited : (46)
|
References (2)
|